Nasdaq Microcap Soars After Unveiling AI Tool Designed to Accelerate Medical Research [Globe and Mail, The (Toronto, Canada)]
iSpecimen Inc. (ISPC)
Company Research
Source: Globe and Mail, The
From drug discovery to clinical data analysis, AI-powered tools are increasingly helping scientists process vast amounts of information and connect critical research resources faster than ever before. One emerging application is the use of intelligent platforms to streamline access to human biospecimens, an essential component in developing diagnostics, therapies, and medical breakthroughs. Shares of iSpecimen Inc. ( NASDAQ: ISPC ) are surging after the company announced the launch of a new AI-powered tool designed to improve the efficiency of its biospecimen marketplace platform. The technology-driven company, which connects life science researchers with a global network of biospecimen suppliers, introduced its new AI-powered Inventory Agent following Thursday's closing bell, helping drive strong momentum in the stock Friday morning. iSpecimen's newly launched AI agent is designed to accelerate the process of reviewing incoming biospecimen requests and matching them with availabl
Show less
Read more
Impact Snapshot
Event Time:
ISPC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ISPC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ISPC alerts
High impacting iSpecimen Inc. news events
Weekly update
A roundup of the hottest topics
ISPC
News
- BC-Most Active Stocks [Yahoo! Finance]Yahoo! Finance
- iSpecimen Launches AI Agent Revolutionizing Biospecimen Matching [Yahoo! Finance]Yahoo! Finance
- iSpecimen Launches AI Agent Revolutionizing Biospecimen MatchingGlobeNewswire
- iSpecimen (NASDAQ:ISPC) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Nuwellis Announces Changes to Board of Directors [Yahoo! Finance]Yahoo! Finance
ISPC
Sec Filings
- 3/13/26 - Form 8-K
- 3/3/26 - Form DEFA14A
- 2/23/26 - Form 8-K
- ISPC's page on the SEC website